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Hailey-Hailey disease (HHD), or familial benign
chronic pemphigus, is an autosomal dominant gen-
odermatosis. In this condition, dysregulation of
intracellular calcium homeostasis leads to impaired
desmosome function and suprabasilar acantholysis
of the epidermis.1 Clinically, this condition presents
as intertriginous vesicles, erosions, and weeping,
fissured plaques.1 The painful nature of HHD, risk of
secondary infection, and malodor can significantly
affect a patient’s quality of life. The lesions are often
difficult to control with topical steroids and antimi-
crobials, necessitating more aggressive treatments.
In previous case reports, ionizing radiation was
found to prolong remission of plaques.2-4 We report
the use of electron beam radiation therapy (EBRT) to
treat 2 patients with recalcitrant HHD.CASE REPORT
Patient 1, a 43-year-old woman, presented with a
15-year history of persistent lesions on her back,
chest, and groin. Physical examination found
extensive, eroded, well-demarcated, erythematous
plaques with honey-colored crust scattered over the
inframammary folds, lower back, and bilateral
inguinal folds (Fig 1). Patient 2, a 67-year-old
woman, presented with a long history of persistent
lesions on her upper thighs and groin. Physical
examination found well-demarcated, erythematous
plaques with a ‘‘wet tissue paper’’ appearance in the
vulva, bilateral groin, and perianal region.
Patient 1 was treated with local radiation
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197. E-mail: pmgraham86@gmail.com.fold and lower back for a total dose of 20 Gy with
near complete resolution and no recurrence after
14 weeks (Figs 2 and 3). A second round of local
radiation (10 fractions of 2 Gy) is scheduled to treat
the left inframammary region. The patient’s residual
lesions are being managed with oral glycopyrrolate,
magnesium supplements, chlorhexidine wash, and
zinc paste.
Patient 2 was treated with local radiation (10
fractions of 2 Gy) to the vulva, bilateral groin, and
perianal skin for a total dose of 20 Gy with complete
remission of her lesions 4 months after radiation
therapy. On 7-month follow-up, the patient had
recurrence in approximately 10% of previously
irradiated skin, which remained well controlled
with oral magnesium supplements, oral glycopyrro-
late, topical calcipotriene, and chlorhexidine wash.
In both patients, additional relief was obtained with
the use of lightweight cotton clothing and avoidance
of hot and humid environments.
DISCUSSION
HHD is an autosomal dominant genodermatosis
caused by a mutation in the ATP2C1 gene. The
resultant loss of cellular adhesion in the epidermis is
from abnormal intracellular calcium signaling and
suprabasilar acantholysis (Fig 4).1 HHD isJAAD Case Reports 2016;2:159-61.
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Fig 1. Hailey-Haileydisease.Patient1: erythematous-crusted
plaques on the lower midback before radiation treatment.
Fig 2. Patient 1: complete resolution of skin lesions on the
lower backwith residual postradiation hyperpigmentation.
Fig 3. Patient 1: complete resolution of skin lesions on the
right inframammary fold with residual postradiation
hyperpigmentation.
Fig 4. Hailey-Hailey disease. Patient 1: suprabasalar and
intraepidermal keratinocyte acantholysis with a ‘‘dilapidated




160 Graham, Melkonian, and Fivensoncharacterized by the presence of vesicular and
erosive plaques that favor the intertriginous areas
of the body. Friction, heat, and sweating tend to
exacerbate the disease andminor traumamay induce
new lesions (K€oebner phenomenon). The clinical
course of the disease is hard to predict, but most
patients experience waxing and waning severity.
Fortunately, there is evidence showing that HHDtends to improve with age, although complete res-
olution is rare.1
Because of the chronicity and recalcitrant nature
of this disease, more invasive treatment options have
been introduced, including Grenz ray therapy (GRT)
and EBRT. Both forms of ionizing radiation alter
DNA, therefore, affecting the reproductive integrity
of cells. In GRT, low energy x-rays penetrate the
superficial epidermis 1 to 2 mm, allowing sufficient
energy to reach the site of pathology while sparing
the germinative layers.4 Notably, the photons travel
as indefinite waves with continued, although dimin-
ished, penetration into deeper tissues, where the
absorption of a given dose of radiation may differ
based on tissue density.5 GRT use in HHD was first
described in 1956 by Sarkany4 (200e400 R, 10 kV) on
a series of 6 patients with reported remissions lasting
from 4 to 14 months. In contrast, EBRT is composed
of electron particles and, therefore, exhibits limited
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beyond a certain depth.5 Absorption is unaffected by
tissue type.5 For HHD, EBRT is targeted at a depth of
2 to 2.5 mm (epidermal).3 In 2010, Narbutt et al2
reported successful EBRT for 3 patients with HHD,
achieving remission for 38 months with a cumulative
dose of 20 Gy administered in 10 fractions (2 Gy once
daily for 5 days per week).
By contrast, one study reported minimal benefit
from EBRT. The authors describe 2 cases of HHD
treated with a cumulative dose of 20 to 35 Gy that
showed initial improvement at the treatment sites
with recurrence by 3 to 5 months.6,7 The authors
reasoned that it was unclear whether the condition
improved because of the remitting-relapsing natural
history of HHD or from the treatment with electron
beam radiation. Even temporary relief can greatly
improve quality of life in severe cases like those
examined in these reports. This finding was
illustrated by a 2008 survey of patients undergoing
ionizing radiation therapy for recalcitrant dermato-
ses, in which most felt radiation treatment was
worthwhile, decreasing the discomfort and severity
of their conditions.8
The favorable results of our study support EBRT
as an option for HHD patients that have not
responded to more conservative therapies. Lasting
effects are likely secondary to direct ionization,
resulting in disturbance of intracellular function,
immunosuppression and inhibition of excessive
epidermal cell proliferation. The adverse effects are
limited to transient erythema, hyperpigmentation of
the previously irradiated site, and an increased risk of
skin cancer development.3 Importantly, EBRT does
not alter the course of systemic disease in non-
irradiated sites.2,3 Therefore, adjuvant therapy is
highly recommended in conjunction with radiation
therapy. Symptoms can be managed with topical
corticosteroids in combination with topical or oral
antibiotics and a gentle cleanser. In 2015, Borghi
et al9 described the use of magnesium chloride in thetreatment of HHD. These authors hypothesized that
MgCl2 acts as an inhibitor of the Ca
21 pump
in keratinocytes, leading to an accumulation of
intracellular Ca21 and promoting increased desmo-
somal assembly.9 In our cases, we believe that
supplementation with MgCl2 was a contributing
factor in the resolution of the lesions. Oral glyco-
pyrrolate has also been reported in helping control
exacerbating factors such as increased moisture and
sweating in HHD.10 Patient education on proper
techniques to reduce heat and friction is also
important. Our results should encourage providers
to consider EBRT when designing the multidimen-
sional treatment plan necessary for treating recalci-
trant HHD.
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